Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial injury in scleroderma.

M B Kahaleh, G K Sherer, E C LeRoy

    The Journal of Experimental Medicine
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Scleroderma and Raynaud's syndrome sera show cytotoxic activity against endothelial cells, suggesting a potential mechanism for vascular damage in these conditions. This finding aids in understanding the disease

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.

    The Journal of steroid biochemistry and molecular biology·2010
    Same author

    Vascular involvement in systemic sclerosis (SSc).

    Clinical and experimental rheumatology·2004
    Same author

    Regulation of substance P mRNA expression in human dermal microvascular endothelial cells.

    Clinical and experimental rheumatology·2004
    Same author

    The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.

    Clinical and experimental rheumatology·2004
    Same author

    Beauty and the beast. The nitric oxide paradox in systemic sclerosis.

    Rheumatology (Oxford, England)·2002
    Same author

    A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis.

    Annals of the rheumatic diseases·2002

    Area of Science:

    • Vascular Biology
    • Immunology
    • Rheumatology

    Background:

    • Scleroderma is associated with vascular lesions, but the cause is unclear.
    • Endothelial cells are key targets for studying vascular damage in scleroderma.
    • In vitro cell culture allows for detailed investigation of cellular responses.

    Purpose of the Study:

    • To investigate the effects of scleroderma serum on various cell types.
    • To identify specific cellular targets of serum-mediated damage in scleroderma.
    • To characterize the nature of cytotoxic factors in patient sera.

    Main Methods:

    • Isolation and culture of endothelial cells, smooth muscle cells, and fibroblasts.
    • Treatment of cell cultures with sera from patients with scleroderma and Raynaud's syndrome.

    Related Experiment Videos

  • Analysis of cell viability and characterization of serum components using gel-filtration chromatography.

    • Main Results:

    • Sera from a significant proportion of scleroderma (31/52) and Raynaud's syndrome (11/19) patients exhibited cytotoxic effects.
    • The observed cytotoxicity was specifically targeted towards endothelial cells.
    • The cytotoxic factor was found to be nondialyzable, heat-stable, and associated with albumin.

    Conclusions:

    • Scleroderma and Raynaud's syndrome sera contain endothelial cell-specific cytotoxic activity.
    • This activity may contribute to the vascular pathology observed in scleroderma.
    • Further research into these cytotoxic factors could reveal novel therapeutic targets.